OpportunityTitle: Type 1 Diabetes TrialNet Clinical Centers (U01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Only Non-domestic (non-U.S.) Entities (Foreign Institutions) located in North America are eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Only foreign components, as defined in the NIH Grants Policy Statement, that are located in North America are allowed.
Description: Type 1 Diabetes TrialNet is an international consortium of clinical research centers aimed at the delay or prevention of type 1 diabetes (T1D). This opportunity will provide infrastructure support for TrialNet Clinical Centers, allowing them to recruit, treat, and follow subjects in TrialNet studies and trials. In addition, funding will be provided for Clinical Centers to support Affiliate Sites. In addition to this opportunity, a separate, new TrialNet unit is planned, the Clinical Network Hub (CNH). The CNH will focus on the coordination and enhancement of screening and recruiting activities.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;